These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
153 related items for PubMed ID: 6795229
1. Active immunization with lipopolysaccharide Pseudomonas antigen for chronic Pseudomonas bronchopneumonia in guinea pigs. Pennington JE, Hickey WF, Blackwood LL, Arnaut MA. J Clin Invest; 1981 Nov; 68(5):1140-8. PubMed ID: 6795229 [Abstract] [Full Text] [Related]
10. Host defense mechanisms against pneumonia due to Pseudomonas aeruginosa. Pennington JE, Ehrie MG, Hickey WF. Rev Infect Dis; 1984 Jun 18; 6 Suppl 3():S657-66. PubMed ID: 6443767 [Abstract] [Full Text] [Related]
11. Experimental chronic Pseudomonas aeruginosa lung infection in rats. Non-specific stimulation with LPS reduces lethality as efficiently as specific immunization. Lange KH, Hougen HP, Høiby N, Fomsgaard A, Rygaard J, Johansen HK. APMIS; 1995 May 18; 103(5):367-74. PubMed ID: 7654361 [Abstract] [Full Text] [Related]
12. Impact of molecular biology on Pseudomonas aeruginosa immunization. Pennington JE. J Hosp Infect; 1988 Feb 18; 11 Suppl A():96-102. PubMed ID: 2896754 [Abstract] [Full Text] [Related]
13. Human IgG antibodies to Pseudomonas aeruginosa core lipopolysaccharide determinants are detected in chronic but not acute pseudomonas infection. Jacobson MA, Radolf JD, Young LS. Scand J Infect Dis; 1987 Feb 18; 19(6):649-60. PubMed ID: 3126549 [Abstract] [Full Text] [Related]
14. Protection against fatal Pseudomonas aeruginosa sepsis by immunization with smooth and rough lipopolysaccharides. Cryz SJ, Meadow PM, Fürer E, Germanier R. Eur J Clin Microbiol; 1985 Apr 18; 4(2):180-5. PubMed ID: 3924605 [Abstract] [Full Text] [Related]
15. Evaluation of a new polyvalent Pseudomonas vaccine in respiratory infections. Pennington JE, Miler JJ. Infect Immun; 1979 Sep 18; 25(3):1029-34. PubMed ID: 115786 [Abstract] [Full Text] [Related]
18. Active and passive immunity against Pseudomonas aeruginosa with a ribosomal vaccine and antiserum in C3H/HeJ mice. Lieberman MM, Ayala E. J Immunol; 1983 Jul 18; 131(1):1-3. PubMed ID: 6408166 [No Abstract] [Full Text] [Related]
19. Vaccination promotes TH1-like inflammation and survival in chronic Pseudomonas aeruginosa pneumonia. A new prophylactic principle. Johansen HK, Cryz SJ, Hougen HP, Moser C, Høiby N. Behring Inst Mitt; 1997 Feb 18; (98):269-73. PubMed ID: 9382750 [Abstract] [Full Text] [Related]
20. Preparation and characterization of a nontoxic polysaccharide-protein conjugate that induces active immunity and passively protective antibody against Pseudomonas aeruginosa immunotype 1 in mice. Tsay GC, Collins MS. Infect Immun; 1984 Jul 18; 45(1):217-21. PubMed ID: 6429046 [Abstract] [Full Text] [Related] Page: [Next] [New Search]